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Background: This randomized prospective study compared the treat-
ment of superficial femoral artery occlusive disease percutaneously with an
expanded polytetrafluoroethylene (ePTFE)/nitinol self-expanding stent
graft vs surgical femoral to above knee popliteal artery bypass with synthetic
graft material.
Methods: One hundred limbs in 86 patients with superficial femoral
artery occlusive disease were evaluated fromMarch 2004 toMay 2005. Patient
symptoms included claudication and limb-threatening ischemiawith orwithout
tissue loss. Trans-Atlantic InterSociety Consensus (TASC II) A (n 18), B (n
 56), C (n  11), and D (n  15) lesions were included. Patients were
randomized prospectively into a percutaneous treatment group (group A; n
50) with angioplasty and placement of one or more stent grafts or a surgical
treatment group (groupB; n50)with a femoral to above knee popliteal artery
bypass using synthetic conduit (Dacron or ePTFE). Patients were followed up
for 48 months. Follow-up evaluation included clinical assessment, physical
examination, ankle-brachial indices (ABI), and color flow duplex ultrasound
imaging at 3, 6, 9, 12, 18, 24, 36, and 48 months.
Results: Mean (standard deviation) total lesion length of the treated
arterial segment in the stent graft group was 25.6 (15) cm. The stent graft
group demonstrated a primary patency of 72%, 63%, 63%, and 59% with a
secondary patency of 83%, 74%, 74%, and 74% at 12, 24, 36, and 48months,
respectively. The surgical femoral-popliteal group demonstrated a primary
patency of 76%, 63%, 63%, and 58%, with a secondary patency of 86%, 76%,
76%, and 71% at 12, 24, 36, and 48 months, respectively. No statistical
difference was found between the two groups with respect to primary (P 
.807) or secondary patency (P  .891). A statistical difference was found in
limb salvage and amputation-free survival at 48 months, however, with limb
salvage rates of 98% in the stent graft group and 84% in the surgical group (P
 .039).
Conclusions: Management of superficial femoral artery occlusive dis-
ease with percutaneous stent grafts exhibits similar primary patency at 4-year
(48-month) follow-up compared with conventional femoral-popliteal artery
bypass grafting with synthetic conduit. This treatment method may offer an
alternative to treatment of the superficial femoral artery segment for revas-
cularization when a prosthetic bypass is being considered or when autolo-
gous conduit is unavailable.
Restenosis Following Carotid Endarterectomy in a Multicenter Re-
gional Registry
Philip P. Goodney,1 Brian W. Nolan,1 Jens Eldrup-Jorgensen,2 Andrew C.
Stanley,3 Donald S. Likosky,1 and Jack L. Cronenwett,1 From Dartmouth-
Hitchcock, Lebanon, NH1; Maine Medical Center, Portland, Me2; and
Fletcher Allen Healthcare, University of Vermont, Burlington, Vt.
3 Lebanon, NH; Portland, Me; and Burlington, Vt
Background: Level I evidence has shown that patch angioplasty, when
used during conventional carotid endarterectomy (CEA), results in lower
Fig 1. Rate of patch angioplasty after conventional carotid end-
arterectomy.rates of restenosis. However, it remains unclear how this information has
affected practice patterns and outcomes in real-world vascular surgery set-
tings.
Methods:Within the Vascular Study Group of NorthernNewEngland
(VSGNNE), we studied 2934 patients undergoing 3118 first-time CEA
between January 1, 2003, and December 31, 2007. Rates of restenosis
(defined as on duplex ultrasound imaging at 1-year follow-up) were calcu-
lated using life-table analysis. Cox proportional-hazardsmodels were used to
identify multivariate predictors of restenosis.
Results:Overall, 2724 patients (87%) underwent conventional CEA, and
394 (13%) underwent eversion CEA. The proportion conventional CEAs
performedwith patching increased over time, from87% in 2003 to 95% in 2008
(P  .001; Fig 1). Concomitantly, the use of eversion CEA declined signifi-
cantly, from 17% of all cases in 2003 to 8% of all cases in 2007 (P  .001).
Restenosis occurred in 313 patients (10%) but most commonly was noncritical
in nature: 7.6% had a 50% to 80% restenosis, 1.8% had an 80% to 99% restenosis,
and 0.5% had an occlusion.Univariate analyses showed significant differences in
critical (80% to 99%) restenosis by procedure type (1.1 % in conventional CEA,
6.6% in eversion CEA, P  .002), the year of procedure (3% in 2003, 0.6% in
2008, P  .03), and use of patching (2.9% no patch, 1.0% with patch, P 
.008). Among patients undergoing conventional CEA, multivariate analysis
demonstrated that surgery in a hospital with a high restenosis rate in prior years
(hazard ratio [HR], 2.6; 95% confidence interval [CI], 1.4-4.9), absence of
patching (HR, 2.7; 95% CI, 1.3-5.4), and contralateral 80% internal carotid
artery stenosis (HR, 3.2; 95% CI 1.5-7.0) were independently associated with a
higher risk of an 80% to 99% restenosis at 1 year (Fig 2). Reintervention was
performed1 year in 13 of 58 patients with 80% to 99% restenosis, consisting
of three reoperations and 10 carotid artery stent procedures. Of the 16 patients
with a carotid occlusion1 year, one patient sustained a major stroke and one
a minor stroke.
Conclusions: In our region, clinically significant restenosis after CEA
fell slightly over time, associated with an increase in patching and a decline in
the use of eversion endarterectomy. Other factors, such as the degree of
contralateral stenosis, also affected restenosis rates after CEA. Quality im-
provement efforts aimed toward increasing the use of patch angioplasty may
offer an opportunity to limit restenosis after CEA.
Subintimal Angioplasty of Chronic Total Occlusion in Iliac Arteries: A
Safe and Durable Option
Brian L. Chen, Harry R. Holt, Jarrod D. Day, Christopher L. Stout, William
Veale, Gordon K. Stokes, and Jean M. Panneton, From the Division of
Vascular Surgery, Eastern Virginia Medical School. Norfolk, Va
Background: Aortofemoral bypass has traditionally been the interven-
tion of choice for chronic total occlusions (CTO) of iliac arteries. However,
it is associated with significant mortality and morbidity, making this proce-
dure prohibitive in high-risk patients. To reduce procedural risk, many have
used subintimal angioplasty (SIA) for femoropopliteal CTO, but few have
extended this endovascular technique to treating iliac CTOs.We present out
experience with 101 successful SIAs in iliac artery CTO.
Methods: A retrospective review of consecutive patients with iliac
artery CTO treated with SIA from June 2000 to July 2009 was completed.
Fig 2. Restenosis rate after carotid endarterectomy in the Vascu-
lar Study Group of Northern New England, 2003-2007.Demographic, risk factor data, and procedural data were obtained. Primary
and secondary patency was determined by Kaplan-Meier survival analysis.
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